Prices delayed by at least 15 minutes | Print
Xtrackers (Ie) Public Limited Company X USD CORP BOND SRI PAB UCITS ETF
Open
£31.715
Previous close
£31.5775
Trade high
£31.715
Year low
£29.87
Year high
£32.42
Replication method
Physical Sample
Volume
574
Type
ETF
UCITS
Yes
Dividend yield
-
Ongoing charge
0.16
ISIN
IE00BL58LJ19
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Asset allocation
Top 10 holdings
Holdings 31/03/2024 | % of assets |
---|---|
Dws Deutsche Gls - Managed Dollar Fund Z-Class | 0.46 |
CVS Health Corp 5.05% | 0.38 |
Pfizer Investment Enterprises Pte Ltd. 5.3% | 0.31 |
WarnerMedia Holdings Inc. 5.141% | 0.28 |
Amgen Inc. 5.65% | 0.24 |
AbbVie Inc. 4.25% | 0.24 |
Microsoft Corporation 2.921% | 0.23 |
Goldman Sachs Group, Inc. 6.75% | 0.23 |
CVS Health Corp 4.78% | 0.22 |
CVS Health Corp 4.3% | 0.22 |
Investment objective
The investment objective of the Fund is to track the performance before fees and expenses of the Underlying Asset, which is the Bloomberg MSCI USD Liquid Investment Grade Corporate SRI PAB Index (the "Reference Index").
Asset class
ETFMorningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.